Particle transport in therapeutic magnetic fields

Annual Review of Fluid Mechanics

Volumn 46, Issue , 2014, Pages 407-440

  Puri, Ishwar K ^a   Ganguly, Ranjan ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b JADAVPUR UNIVERSITY   (India)

Author keywords

Ferrofluids; Magnetic drug targeting; Magnetic fluid hyperthermia; Magnetic microspheres; Magnetic nanoparticles; Microfluidic biosensors

Indexed keywords

MAGNETIC DRUG TARGETING; MAGNETIC FLUID HYPERTHERMIA; MAGNETIC MICROSPHERES; MAGNETIC NANO-PARTICLES; MICROFLUIDIC BIOSENSORS;

AMORPHOUS FILMS; BIOMEMS; MAGNETIC FLUIDS; MAGNETISM; MICROFLUIDICS; MICROSPHERES; NANOPARTICLES; PARTICLE SEPARATORS; TRANSPORT PROPERTIES;

MAGNETIC BUBBLES;

DRUG; ELECTRODYNAMICS; FLUID FLOW; HYDRODYNAMICS; IRON OXIDE; MAGNETIC FIELD; MOMENTUM; NANOTECHNOLOGY; PARTICLE MOTION; SENSOR;

EID: 84891765656     PISSN: 00664189     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev-fluid-010313-141413     Document Type: Article

References (155)

1. Alexiou C, Arnold W, Klein RJ, Parak FG, Hulin P, et al. 2000. Locoregional cancer treatment with magnetic drug targeting. Cancer Res. 60:6641-48
2. Alexiou C, Jurgons R, Schmid RJ, Bergemann C, Henke J, et al. 2003. Magnetic drug targeting: Biodistribution of themagnetic carrier and the chemotherapeutic agentmitoxantrone after locoregional cancer treatment. J. Drug Target. 11:139-49
3. Alexiou C, Jurgons R, Schmidt R, Hilpert A, Bergemann C, et al. 2005. In vivo and in vitro investigation of targeted chemotherapy with magnetic nanoparticles. J. Magn. Magn. Mater. 293:389-93
4. Alexiou C, Schmidt A, Klein R, Hulin P, Bergemann C, Arnold W. 2002. Magnetic drug targeting: Biodistribution and dependency on magnetic field strength. J. Magn. Magn. Mater. 252:363-66
5. Arruebo M, Ferńandez-Pacheco R, Ibarra MR, Santamaría J. 2007. Magnetic nanoparticles for drug delivery. Nano Today 2:22-32
6. Avilés MO, Ebner AD, Chen H, Rosengart AJ, Kaminski MD, Ritter JA. 2005. Theoretical analysis of a transdermal ferromagnetic implant for retention of magnetic drug carrier particles. J. Magn. Magn. Mater. 293:605-15
7. Avilés MO, Ebner AD, Ritter JA. 2008. Implant assisted-magnetic drug targeting: Comparison of in vitro experiments with theory. J. Magn. Magn. Mater. 320:2704-13
8. Babinec P, Krafcík A, Babincov́aM, Rosenecker J. 2010. Dynamics of magnetic particles in cylindrical Halbach array: Implications for magnetic cell separation and drug targeting. Med. Biol. Eng. Comput. 48:745-53
9. Bagaria HG, Johnson DT. 2005. Transient solution to the bioheat equation and optimization for magnetic fluid hyperthermia treatment. Int. J. Hyperth. 21:57-75
10. Back LH, Banerjee RK. 2000. Estimated flow resistance increase in a spiral human coronary artery segment. J. Biomech. Eng. 122:675-77
11. Banerjee MK, Datta A, Ganguly R. 2010. Magnetic drug targeting in partly occluded blood vessels using magnetic microspheres. ASME J. Nanotechnol. Eng. Med. 1:041005
12. Banerjee U, Bit P, Ganguly R, Hardt S. 2012. Aggregation dynamics of particles in a microchannel due to an applied magnetic field. Microfluid. Nanofluid. 13:565-77
13. Berkovsky BM, ed. 1978. Thermomechanics ofMagnetic Fluids: Theory and Applications; Proceedings of the International Advanced Course andWorkshop on Thermomechanics ofMagnetic Fluids. Washington, DC: Hemisphere
14. Blüms E, Pļaviš J, Chukhrov A. 1983. High-gradient magnetic separation of magnetic colloids and suspensions. J. Magn. Magn. Mater. 39:147-51
15. Brade AM, Szmitko P, Ngo D, Liu FF, Klamut HJ. 2003. Heat-directed suicide gene therapy for breast cancer. Cancer Gene Ther. 10:294-301
16. Brismar TB, Grishenkov D, Gustafsson B, Härmark J, Barrefelt Á, et al. 2012. Magnetite nanoparticles can be coupled to microbubbles to support multimodal imaging. Biomacromolecules 13:1390-99
17. Bronzeau S, Pamme N. 2008. Simultaneous bioassays in a microfluidic channel on plugs of different magnetic particles. Anal. Chim. Acta 609:105-12
18. Bu M, Christensen TB, Smistrup K, Wolff A, Hansen MF. 2008. Characterization of a microfluidic magnetic bead separator for high-Throughput applications. Sens. Actuators A 145-146:430-36
19. Büscher K, Helm CA, Gross C, Glöckl G, Romanus E, Weitschies W. 2004. Nanoparticle composition of a ferrofluid and its effects on the magnetic properties. Langmuir 20:2435-44
20. Candeo A, Dughiero F. 2009. Numerical FEM models for the planning of magnetic induction hyperthermia treatments with nanoparticles. IEEE Trans. Magn. 45:1658-61
21. Cascinu S, Catalano V, Baldelli AM, Scartozzi M, Battelli N, et al. 1998. Locoregional treatments of unresectable liver metastases from colorectal cancer. Cancer Treat. Rev. 24:3-14
22. Chatterjee J, Haik Y, Chen C-J. 2001. Modification and characterization of polystyrene-based magnetic microspheres and comparisonwith albumin-based magnetic microspheres. J. Magn.Magn.Mater. 225:21-29
23. Chauhan VP, Stylianopoulos T, Boucher Y, Jain RK. 2011. Delivery of molecular and nanoscale medicine to tumors: Transport barriers and strategies. Annu. Rev. Chem. Biomol. Eng. 2:281-98
24. Chen H, Ebner AD, Kaminski MD, Rosengarten AJ, Ritter JA. 2005. Analysis ofmagnetic drug carrier particle capture by a magnetizable intravascular stent-2: Parametric study with multi-wire two-dimensional model. J. Magn. Magn. Mater. 293:616-32
25. Choi J-H, Oh KW, Thomas JH, Heineman WR, Halsall HB, et al. 2002. An integrated microfluidic biochemical detection system for protein analysis with magnetic bead-based sampling capabilities. Lab Chip 2:27-30
26. Chorny M, Fishbein I, Yellen BB, Alferiev IS, Bakay M, et al. 2010. Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields. Proc. Natl. Acad. Sci. USA 107:8346-51
27. Chung S-H, Hoffmann A, Guslienko K, Bader SD, Liu C, et al. 2005. Biological sensing with magnetic nanoparticles using Brownian relaxation. J. Appl. Phys. 97:10R101
28. Clift R, Grace JR, Weber ME. 1978. Bubbles, Drops, and Particles. New York: Academic
29. Colombo M, Carregal-Romero S, Casula MF, Gutiérrez L, Morales MP, et al. 2012. Biological applications of magnetic nanoparticles. Chem. Soc. Rev. 41:4306-34
30. Cortivo R, Vindigni V, Iacobellis L, Abatangelo G, Pinton P, Zavan B. 2010. Nanoscale particle therapies for wounds and ulcers. Nanomedicine 5:641-56
31. Creighton FM. 2006. Optimal distribution of magnetic material for catheter and guidewire cardiology therapies. Proc. Magn. Conf. 2006. INTERMAG 2006, p. 111. New York: IEEE Int.
32. Dance SL, Climent E, Maxey MR. 2004. Collision barrier effects on the bulk flow in a random suspension. Phys. Fluids 16:828-31
33. Dobson J. 2006. Gene therapy progress and prospects: Magnetic nanoparticle-based gene delivery. Gene Ther. 13:283-87
34. Dubus S, Gravel JF, Le Drogoff B, Nobert P, Veres T, Boudreau D. 2006. PCR-free DNA detection using a magnetic bead supported polymeric transducer and microelectromagnetic traps. Anal. Chem. 78:4457-64
35. Edelstein RL, Tamanaha CR, Sheehan PE, Miller MM, Baselt DR, et al. 2000. The BARC biosensor applied to the detection of biological warfare agents. Biosens. Bioelectron. 14:805-13
36. Falk MH, Issels RD. 2001. Hyperthermia in oncology. Int. J. Hyperth. 17:1-18
37. Fertman VE. 1988. Magnetic Fluids Handbook: Properties and Application.Washington, DC: Hemisphere
38. Forbes ZG, Yellen BB, Halverson DS, Fridman G, Barbee KA, Friedman G. 2008. Validation of high gradient magnetic field based drug delivery tomagnetizable implants under flow. IEEE Trans. Biomed. Eng. 55:643-49
39. Furlani EJ, Furlani EP. 2007. A model for predicting magnetic targeting of multifunctional particles in the microvasculature. J. Magn. Magn. Mater. 312:187-93
40. Furlani EP. 2006. Analysis of particle transport in a magnetophoretic microsystem. J. Appl. Phys. 99:024912
41. Furdui VI, Harrison DJ. 2004. ImmunomagneticTcell capture from blood for PCRanalysis using microfluidic systems. Lab Chip 4:614-18
42. Gao W, Kagan D, Pak OS, Clawson C, Campuzano S, et al. 2012. Cargo-Towing fuel-freemagnetic nanoswimmers for targeted drug delivery. Small 8:460-67
43. steady forced flow. Ganguly R, Gaind AP, Puri IK. 2005. A strategy for the assembly of three-dimensional mesoscopic structures using a ferrofluid. Phys. Fluids 17:057103
44. Ganguly R, Gaind AP, Sen S, Puri IK. 2005. Analyzing ferrofluid transport for magnetic drug targeting. J. Magn. Magn. Mater. 289:331-34
45. Ganguly R, Hahn T, Hardt S. 2010. Magnetophoretic mixing for in situ immunochemical binding on magnetic beads in a microfluidic channel. Microfluid. Nanofluid. 8:739-53
46. Ganguly R, Zellmer B, Puri IK. 2005. Field-induced self-Assembled ferrofluid aggregation in pulsatile flow. Phys. Fluids 17:097104
47. Gerber R, Takayasu M, Friedlander F. 1983. Magnetic separation of submicron particles. IEEE Trans. Magn. 19:2112-14
48. Gillies GT, Ritter RC, Broaddus WC, Grady MS, HowardMA III, McNeil RG. 1994. Magnetic manipulation instrumentation for medical physics research. Rev. Sci. Instrum. 65:533-45
49. Goodwin S, Peterson C, Hoh C, Bittner C. 1999. Targeting and retention of magnetic targeted carriers (MTCs) enhancing intra-Arterial chemotherapy. J. Magn. Magn. Mater. 194:132-39
50. Griffiths DJ. 2004. Introduction to Electrodynamics. Englewood Cliffs, NJ: Prentice Hall
51. Habib AH, Ondeck CL, Chaudhary P, Bockstaller MR, McHenry ME. 2008. Evaluation of iron-cobalt/ferrite core-shell nanoparticles for cancer thermotherapy. J. Appl. Phys. 103:7A307
52. Häfeli UO, Gilmour K, Zhou A, Lee S, Hayden ME. 2007. Modeling ofmagnetic bandages for drug targeting: Button versus Halbach arrays. J. Magn. Magn. Mater. 311:323-29
53. Haik Y, Chen C-J, Chatterjee J. 2002. Numerical simulation of biomagnetic fluid in a channel with thrombus. J. Vis. 5:187-95
54. Haik Y, Pai V, Chen CJ. 1999. Biomagnetic fluid dynamics. In Fluid Dynamics at Interfaces, ed. W Shyy, R Narayanan, pp. 439-52. Cambridge, UK: Cambridge Univ. Press
55. Halbach K. 1980. Design of permanent multipole magnets with oriented rare earth cobalt material. Nucl. Instrum. Methods 169:1-10
56. Hayden ME, Häfeli UO. 2006. "Magnetic bandages" for targeted delivery of therapeutic agents. J. Phys. Condens. Matter 18:S2877-91
57. Holligan DL, Gillies GT, Dailey JP. 2003. Magnetic guidance of ferrofluidic nanoparticles in an in vitro model of intraocular retinal repair. Nanotechnology 14:661-66
58. Hoŕak D, BabiçM, Mackov́aH, BeneşMJ. 2007. Preparation and properties ofmagnetic nano- andmicrosized particles for biological and environmental separations. J. Sep. Sci. 30:1751-72
59. Hosono T, Takahashi H, Fujita A, Joseyphus RJ, Tohji K, Jeyadevan B. 2009. Synthesis ofmagnetite nanoparticles for AC magnetic heating. J. Magn. Magn. Mater. 321:3019-23
60. Hwu J, Lin YS, Josephrajan T, Hsu M-H, Cheng F-Y, et al. 2009. Targeted paclitaxel by conjugation to iron oxide and gold nanoparticles. J. Am. Chem. Soc. 131:66-68
61. Iacob Gh, Rotariu O, Strachan NJC, Häfeli UO. 2004. Magnetizable needles and wires: Modeling an efficient way to target magnetic microspheres in vivo. Biorheology 41:599-612
62. Inglis DW, Riehn R, Austin RH, Sturm JC. 2004. Continuous microfluidic immunomagnetic cell separation. Appl. Phys. Lett. 85:5093-95
63. Ishiyama K, Sendoh M, Yamazaki A, Arai KI. 2001. Swimming micro-machine driven by magnetic torque. Sens. Actuators 91:141-44
64. Issels RD. 2008. Hyperthermia adds to chemotherapy. Eur. J. Cancer 44:2546-54
65. Johannsen M, Gneveckow U, Eckelt L, Feussner A, Waldöfner N, et al. 2005. Clinical hyperthermia of prostate cancer using magnetic nanoparticles: Presentation of a new interstitial technique. Int. J. Hyperth. 21:637-47
66. Johannsen M, Gneveckow U, Thiesen B, Taymoorian K, Cho CH, et al. 2007. Thermotherapy of prostate cancer using magnetic nanoparticles: Feasibility, imaging, and three-dimensional temperature distribution. Eur. Urol. 52:1653-62
67. Jordan A, Scholz R, Maier-Hauff K, Johannsen M, Wust P, et al. 2001. Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia. J. Magn. Magn. Mater. 225:118-26
68. Jiang G, Harrison DJ. 2000. mRNA isolation in a microfluidic device for eventual integration of cDNA library construction. Analyst 125:2176-79
69. Kantor AB, Gibbons I, Miltenyi S, Schmitz J. 1998. Magnetic cell sorting with colloidal superparamagnetic particles. In Cell Separation Methods and Applications, ed. D Recktenwald, A Radbruch, pp. 153-73. New York: Marcel Dekker
70. Kappiyoor R, Liangruksa M, Ganguly R, Puri IK. 2010. The effects of magnetic nanoparticle properties on magnetic fluid hyperthermia. J. Appl. Phys. 108:094702
71. Kim D, Choi H. 2003. Laminar flow past a hemisphere. Phys. Fluids 15:2457-60
72. Kim KH, Kim MJ, Choa YH, Kim DH, Yu JH. 2008. Synthesis and magnetic properties of surface coated magnetite superparamagnetic nanoparticles. IEEE Trans. Magn. 44:2940-43
73. Kim KS, Park J-K. 2005. Magnetic force-based multiplexed immunoassay using superparamagnetic nanoparticles in microfluidic channel. Lab Chip 5:657-64
74. Kopke RD, Wassel RA, Mondalek F, Grady B, Chen K, et al. 2006. Magnetic nanoparticles: Inner ear targeted molecule delivery and middle ear implant. Audiol. Neurotol. 11:123-33
75. Kreuter J. 1983. Evaluation of nanoparticles as drug delivery systems I: Preparation methods. Pharm. Acta Helv. 58:196-209
76. Lange A. 2002. Kelvin force in a layer of magnetic fluid. J. Magn. Magn. Mater. 241:327-29
77. Lesniak MS, Brem H. 2004. Targeted therapy for brain tumours. Nat. Rev. Drug Discov. 3:499-508
78. Liangruksa M, Ganguly R, Puri IK. 2011. Parametric investigation of heating due to magnetic fluid coefficients, IT and IN.hyperthermia in a tumor with blood perfusion. J. Magn. Magn. Mater. 323:708-16
79. Lin C-T, Liu K-C. 2009. Estimation for the heating effect of magnetic nanoparticles in perfused tissues. Int. Commun. Heat Mass Transf. 36:241-44
80. Lin Y, Zhang B, Yan B. 2011. Enabling anticancer therapeutics by nanoparticle carriers: The delivery of paclitaxel. Int. J. Mol. Sci. 12:4395-413
81. Liu C-J, Lien KY, Weng CY, Shin JW, Chang TY, Lee GB. 2009. Magnetic-bead-based microfluidic system for ribonucleic acid extraction and reverse transcription processes. Biomed. Microdevices 11:339-50
82. Lübbe AS, Alexiou C, Bergemann C. 2001. Clinical applications of magnetic drug targeting. J. Surg. Res. 95:200-6
83. Lübbe AS, Bergemann C, Huhnt W, Fricke T, Riess H, et al. 1996. Preclinical experiences with magnetic drug targeting: Tolerance and efficacy. Cancer Res. 56:4694-701
84. Mahjoob S, Vafai K. 2009. Analytical characterization of heat transport through biological media incorporating hyperthermia treatment. Int. J. Heat Mass Transf. 52:1608-18
85. Mahmoudi M, Sant S, Wang B, Laurent S, Sen T. 2011. Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface modification and applications in chemotherapy. Adv. Drug Deliv. Rev. 63:24-46
86. Mardinoglu A, Cregg PJ, Murphy K, Curtin C, Prina-Mello A. 2011. Theoretical modelling of physiologically stretched vessel inmagnetisable stent assisted magnetic drug targeting application. J. Magn.Magn.Mater. 323:324-29
87. McCloskey KE, Chalmers JJ, Zborowski M. 2003. Magnetic cell separation: Characterization of magnetophoretic mobility. Anal. Chem. 75:6868-74
88. McNab TK, Fox RA, Boyle AJF. 1968. Some magnetic properties ofmagnetite (Fe3O4)microcrystals. J. Appl. Phys. 39:5703-11
89. Mefford OT, Woodward RC, Goff JD, Vadala TP St. Pierre TG, et al. 2007. Field-induced motion of ferrofluids through immiscible viscous media: Testbed for restorative treatment of retinal detachment. J. Magn. Magn. Mater. 311:347-53
90. Mironov V, Kasyanov V, Markwald RR. 2008. Nanotechnology in vascular tissue engineering: From nanoscaffolding towards rapid vessel biofabrication. Trends Biotechnol. 26:338-44
91. Mitsumori M, Hiraoka M, Shibata T, Okuno Y, Nagata Y, et al. 1996. Targeted hyperthermia using dextran magnetite complex: A new treatment modality for liver tumors. Hepatogastroenterology 43:1431-37
92. Modak N, Datta A, Ganguly R. 2009. Cell separation in a microfluidic channel using magnetic microspheres. Microfluid. Nanofluid. 6:647-60
93. Modak N, Kejriwal D, Nandy K, Datta A, Ganguly R. 2010. Experimental and numerical characterization of magnetophoretic separation for MEMS-based biosensor applications. Biomed. Microdevices 12:23-34
94. Moghimi MM, Hunter AC, Murray JC. 2001. Long-circulating and target-specific nanoparticles: Theory to practice. Pharmacol. Rev. 53:283-318
95. Mornet S, Vasseur S, Grasset F, Duguet E. 2004. Magnetic nanoparticle design for medical diagnosis and therapy. J. Mater. Chem. 14:2161-75
96. Moroz P, Jones SK, Gray BN. 2002. Magnetically mediated hyperthermia: Current status and future directions. Int. J. Hyperth. 18:267-84
97. Müller HW, Engel A. 1999. Dissipation in ferrofluids: Mesoscopic versus hydrodynamic theory. Phys. Rev. E 60:7001-9
98. Müller RH, Lück M, Harnisch S, Thode K. 1997. Intravenously injected particles: Surface properties and interaction with blood proteins; the key determining the organ distribution. In Scientific and Clinical Applications of Magnetic Carriers, ed.WSchütt, J Teller, U Häfeli, M Zborowski, pp. 135-48. New York: Springer
99. Nandy K, Chaudhuri S, Ganguly R, Puri IK. 2008. Analytical model for the magnetophoretic capture of magnetic microspheres in microfluidic devices. J. Magn. Magn. Mater. 320:1398-405
100. Odenbach S. 2003. Ferrofluids: Magnetically controlled suspensions. Colloids Surf. A 217:171-78
101. Ohashi T, Kuyama H, Suzuki K, Nakamura S. 2008. Control of aqueous droplets using magnetic and electrostatic forces. Anal. Chim. Acta 612:218-25
102. Oshinski JN, Yoganathan AP. 2008. Comparison of particle image velocimetry and phase contrast MRI in a patient-specific extracardiac total cavopulmonary connection. J. Biomech. Eng. 130:041004
103. Pamme N, Wilhem C. 2006. Continuous sorting of magnetic cells via on-chip free-flow magnetophoresis. Lab Chip 6:974-80
104. Pankhurst QA, Connolly J, Jones SK, Dobson J. 2003. Applications of magnetic nanoparticles in biomedicine. J. Phys. D 36:R167-81
105. Pennes HH. 1948. Analysis of tissue and arterial blood temperatures in the resting human forearm. J. Appl. Physiol. 1:93-122
106. Perea H, Aigner J, Heverhagen JT, Hopfner U, Wintermantel E. 2007. Vascular tissue engineering with magnetic nanoparticles: Seeing deeper. J. Tissue Eng. Regen. Med. 1:318-21
107. Polyak B, Fishbein I, Chorny M, Alferiev I, Williams D, et al. 2008. High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents. Proc. Natl. Acad. Sci. USA 105:698-703
108. Pouliquen D, Perdrisot R, Ermias A, Jallet P, LeJeune JJ. 1989. Superparamagnetic iron oxide nanoparticles as a liver MRI contrast agent: Contribution of microencapsulation to improved biodistribution. Magn. Reson. Imaging 7:619-27
109. Probestein RF. 1994. Physicochemical Hydrodynamics. New York:Wiley
110. Qiao R, Jia Q, Huwel A, Xia R, Liu T, et al. 2012. Receptor-mediated delivery of magnetic nanoparticles across the blood-brain barrier. ACS Nano 6:3304-10
111. Rabin Y. 2002. Is intracellular hyperthermia superior to extracellular hyperthermia in the thermal sense? Int. J. Hyperth. 18:194-202
112. Rahmer J, Weizenecker J, Gleich B, Borgert J. 2012. Analysis of a 3-D system functionmeasured for magnetic particle imaging. IEEE Trans. Med. Imaging 31:1289-99
113. Reddy LH, Couvreur P. 2011. Nanotechnology for therapy and imaging of liver diseases. J. Hepatol. 55:1461-66
114. Rida A, Gijs MAM. 2004. Manipulation of self-Assembled structures ofmagnetic beads formicrofluidicmixing and assaying. Anal. Chem. 76:6239-46
115. Ritter JA, Ebner AD, Daniel KD, Stewart KL. 2004. Application of high gradient magnetic separation principles to magnetic drug targeting. J. Magn. Magn. Mater. 280:184-201
116. Robert D, Pamme N, Conjeaud H, Gazeau F, Iles A, et al. 2011. Cell sorting by endocytotic capacity in a microfluidic magnetophoresis device. Lab Chip 11:1902-10
117. Rosensweig RE. 1985. Ferrohydrodynamics. Cambridge, UK: Cambridge Univ. Press
118. Rosensweig RE. 2002. Heatingmagnetic fluidwith alternating magnetic field. J. Magn.Magn.Mater. 252:370-74
119. Rudge S, Peterson C, Vessely C, Koda J, Stevens S, Catterall L. 2001. Adsorption and desorption of chemotherapeutic drugs from a magnetically targeted carrier (MTC). J. Control. Release 74:335-40
120. Rusetski AN, Ruuge EK. 1990. Magnetic fluid as a possible drug carrier for thrombosis treatment. J. Magn. Magn. Mater. 85:299-302
121. Ruuge EK, Rusetski AN. 1993. Magnetic fluids as drug carriers: Targeted transport of drugs by a magnetic field. J. Magn. Magn. Mater. 122:335-39
122. Sarwar A, Nemirovski A, Shapiro B. 2012. OptimalHalbach permanent magnet designs for maximally pulling and pushing nanoparticles. J. Magn. Magn. Mater. 324:742-54
123. Sasso LA, Undar A, Zahn JD. 2011. Autonomous magnetically actuated continuous flow microimmunofluorocytometry assay. Microfluid. Nanofluid. 9:253-65
124. Schildkopf P, Ott OJ, Frey B, Wadepohl M, Sauer R, et al. 2010. Biological rationales and clinical applications of temperature controlled hyperthermia: Implications formultimodal cancer treatments. Curr. Med. Chem. 17:3045-57
125. Schmidt RF, Thews G. 1995. Physiologie des Menschen. Berlin: Springer-Verlag
126. Seliger C, Jurgons R, Wiekhorst F, Eberbeck D, Trahms L, et al. 2007. In vitro investigation of the behaviour of magnetic particles by a circulating artery model. J. Magn. Magn. Mater. 311:358-62
127. Senyei AE, Reich SD, Gonczy C, Widder KJ. 1981. In vivo kinetics of magnetically targeted low-dose doxorubicin. J. Pharm. Sci. 70:39-41
128. Shapiro B. 2009. Towards dynamic control of magnetic fields to focus magnetic carriers to targets deep inside the body. J. Magn. Magn. Mater. 321:1594-99
129. Shapiro B, Dormer BK, Rutel IB. 2010. A two-magnet system to push therapeutic nanoparticles. AIP Conf. Proc. 1311:77-88
130. Shultz MD, Calvin S, Fatouros PP, Morrison SA, Carpenter EE. 2007. Enhanced ferrite nanoparticles asMRI contrast agents. J. Magn. Magn. Mater. 311:464-68
131. Sinha A, Ganguly R, De AK, Puri IK. 2007. Single magnetic particle dynamics in a microchannel. Phys. Fluids 19:117102
132. Sinha A, Ganguly R, Puri IK. 2009. Magnetic separation from superparamagnetic particle suspensions. J. Magn. Magn. Mater. 321:2251-56
133. Sinha A, Ganguly R, Puri IK. 2010. Numerical investigation of flow-Through immunoassay in a microchannel. J. Appl. Phys. 107:034907
134. Shliomis MI, Stepanov VI. 1993. Rotational viscosity of magnetic fluids: Contribution of the Brownian and Néel relaxational processes. J. Magn. Magn. Mater. 122:196-99
135. Smistrup K, Hansen O, Bruus H, Hansen MF. 2005. Magnetic separation in microfluidic systems using microfabricated electromagnets: Experiments and simulations. J. Magn. Magn. Mater. 293:597-604
136. Song CW, Shakil A, Griffin RJ, Okajima K. 1997. Improvement of tumor oxygenation status by mild temperature hyperthermia alone or in combination with carbogen. Semin. Oncol. 24:626-32
137. Sousa JE, Costa MA, Abizaid A, Abizaid AS, Feres F, et al. 2001. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: A quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 103:192-95
138. Spaldin NA. 2003. Magnetic Materials: Fundamentals andDevice Applications.Cambridge, UK: Cambridge Univ. Press
139. Stone R, Willi T, Rosen Y, Mefford OT, Alexis F. 2011. Targeted magnetic hyperthermia. Ther. Deliv. 2:815-38
140. Torchilin VP. 1995. Targeting of drugs and drug carriers within the cardiovascular system. Adv. Drug Deliv. Rev. 17:75-101
141. Tsai H, Fang YS, Fuh CB. 2006. Analytical and preparative applications of magnetic split-flow thin fractionation on several ion-labeled red blood cells. Biomagn. Res. Technol. 4:6
142. Tzirtzilakis EE. 2005. A mathematical model for blood flow in magnetic field. Phys. Fluids 17:077103
143. Van der Zee J. 2002. Heating the patient: A promising approach? Ann. Oncol. 13:1173-84
144. Van Ewijk GA, Vroege GJ, Phillipse AP. 2002. Susceptibility measurements on a fractionated aggregate-free ferrofluid. J. Phys. Condens. Mater 14:4915-25
145. Voltairas PA, Fotiadis DI, Massalas CV. 2001. Elastic stability of silicone ferrofluid internal tamponade (SFIT) in retinal detachment surgery. J. Magn. Magn. Mater. 225:248-55
146. Voltairas PA, Fotiadis DI, Michalis LK. 2002. Hydrodynamics of magnetic drug targeting. J. Biomech. 35:813-27
147. Wang YX, Hussain SM, Krestin GP. 2001. Superparamagnetic iron oxide contrast agents: Physicochemical characteristics and applications in MR imaging. Eur. Radiol. 11:2319-31
148. Widder KJ, Morris RM, Poore GA, Howard DP, Senyei AE. 1983. Selective targeting of magnetic albumin microspheres containing low dose doxorubicin: Total remission in Yoshida sarcoma-bearing rats. Eur. J. Cancer Clin. Oncol. 19:135-39
149. Widder KJ, Senyei AE, Ranney DF. 1979. Magnetically responsive microspheres and other carriers for the biophysical targeting of antitumor agents. Adv. Pharmacol. Chemother. 16:213-71
150. Williams AM, Vlachos PP. 2011. Dispersion of ferrofluid aggregates in steady flows. Phys. Fluids 2011:127102
151. Yamazaki A, Sendoh M, Ishiyama K, Arai KI, Kato R, et al. 2004. Wireless micro swimming machine with magnetic thin film. J. Magn. Magn. Mater. 272-76(Suppl. 1):e1741-42
152. Yellen BB, Forbes ZG, Halverson DS, Fridman G, Barbee KA, et al. 2005. Targeted drug delivery tomagnetic implants for therapeutic applications. J. Magn. Magn. Mater. 293:647-54
153. Zahn M. 1979. Introduction to Electromagnetic Field Theory: A Problem Solving Approach. New York:Wiley
154. Zaytseva NV, Goral VN, Montagnab RA, Baeumner AJ. 2005. Development of a microfluidic biosensor module for pathogen detection. Lab Chip 5:805-11
155. Zborowski M, Sun L, Moore LR, Williams PS, Chalmers JJ. 1999. Continuous cell separation using novel magnetic quadrupole flow sorter. J. Magn. Magn. Mater. 194:224-30